Sidefarma

InícioSidefarmaPT2020

PT2020

We increase competitiveness in an increasingly global market

Sidefarma’s internationalization

Project Identification:

Internationalization – SIDEFARMA, S.A. Project code LISBOA-02-0752-FEDER-021480, LISBOA-05-3560-FSE-021480

Region of intervention Lisbon Beneficiary entity SIDEFARMA – Sociedade Industrial de Expansão Farmacêutica, S.A.

Goals
  • Prospection of new markets/international markets
  • Growth and internationalization of services and products
  • Increase in customer portfolio
  • Increased company visibility
  • Increased skills and knowledge
Activities:
  • Participation in international pharmaceutical fairs (CPhI Barcelona 2016, CPhI Frankfurt 2017 and CPhl Madrid 2018)
  • Web presence through the digital economy (inbound marketing strategy / website development and online content)
  • International brand development and promotion (international / community registration)
  • Prospecting and presence in international markets (prospecting and attracting new customers)
  • International marketing (targeted promotion to specific markets)
  • Introduction of new organizational methods in business practices or external relations
  • Carrying out diagnostic and market studies
  • Update of product dossiers
  • English language training: Business English
Achieved Results:
  • Start of international trade relations
  • Consolidation of existing international trade relations
  • Increase in the customer portfolio (services and products)
  • Increase in exports
Approval Notification:

Approval date 31/10/2016 Start date 17/05/2016 Completion date 30/11/2018

Total eligible cost €208,311.68 Financial support from the European Union ERDF: €67,075.55; ESF: €20,311.40

  • National/regional public financial support | Not applicable

Safer Medicines

Project Identification:

Sidefarma – Development of safer medicines Project code LISBOA-02-0853-FEDER-019403

Region of intervention Lisbon Beneficiary entity SIDEFARMA – Sociedade Industrial de Expansão Farmacêutica, S.A.

Goals:
  • Change in the production process, through the acquisition of new equipment to change the production process
  • Development of new products
  • Maintenance and reinforcement of currently existing relationships
  • Increase in the national and international client portfolio
  • Attracting new customers for contract manufacturing
  • Increase of skills and knowledge of Human Resources
  • Continuous Quality Improvement
Activities:
  • Participation in international pharmaceutical fairs (CPhI Barcelona 2016, CPhI Frankfurt 2017 and CPhl Madrid 2018)
  • Web presence through the digital economy (inbound marketing strategy / website development and online content)
  • International brand development and promotion (international / community registration)
  • Prospecting and presence in international markets (prospecting and attracting new customers)
  • International marketing (targeted promotion to specific markets)
  • Introduction of new organizational methods in business practices or external relations
  • Carrying out diagnostic and market studies
  • Update of product dossiers
  • English language training: Business English
Achieved Results:
  • Increase in the number of products produced by 46% in the post-project year
  • Increased turnover by €911,726.69 in the post-project year
  • Increase in the intensity of exports by 35.52% in the post-project year
Approval Notification:

Approval date 18/08/2016 Start date 29/06/2016 Completion date 28/02/2019

Total eligible cost €1,613,626.57 Financial support from the European Union ERDF: €625,978.51; ESF: €19,472.12

  • National/regional public financial support | Not applicable

Innovation Project

Project Identification:

Sidefarma Innovation Project Project code LISBOA-02-0853-FEDER-046199

Main objective Strengthen the Competitiveness of SMEs

Intervention region Loures Beneficiary entity SIDEFARMA – Sociedade Industrial de Expansão Farmacêutica, S.A.

Goals:
  • Increased production capacity by around 70%;
  • Ability to develop new formulations and new products;
  • Respond to the requirements of the Pharmaceutical Industry;
  • Continuous Quality Improvement.
Achieved Results:
  • Reach a turnover of 10.48 million euros;
  • Increase of the company’s production capacity by 70%;
  • Monitor the technological evolution available in the market (industry 4.0);
Approval Notification:

Approval date 18/12/2019 Start date 30/08/2019 Completion date 31/12/2020

Total eligible cost 2,069,509.26 Euros Financial support from the European Union ERDF – 737,393.65 Euros